Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
about
Exciting new advances in neuro-oncology: the avenue to a cure for malignant gliomaDelineation of radiation therapy target volumes for patients with postoperative glioblastoma: a reviewThe evolving roles and controversies of radiotherapy in the treatment of glioblastomaPolymeric drug delivery for the treatment of glioblastomaGlioblastoma multiforme: emerging treatments and stratification markers beyond new drugsOutcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group.Factors associated with a higher rate of distant failure after primary treatment for glioblastoma.Diffusion tensor imaging for target volume definition in glioblastoma multiforme.What is the most appropriate clinical target volume for glioblastoma?Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma?Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide.Recurrent malignant gliomas.Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma.Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field designPatterns of failure after multimodal treatments for high-grade glioma: effectiveness of MIB-1 labeling indexPatterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution.Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in gliomaRelapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy.Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience.Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats.Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats.Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas.Defining pseudoprogression in glioblastoma multiforme.Molecular pathways and potential therapeutic targets in glioblastoma multiforme.Evaluation of current clinical target volume definitions for glioblastoma using cell-based dosimetry stochastic methods.PET/MRI: Where might it replace PET/CT?PET imaging of glioblastoma multiforme EGFR expression for therapeutic decision guidance.Improved hippocampal dose with reduced margin radiotherapy for glioblastoma multiforme.MRI during radiotherapy of glioblastoma : Does MRI allow for prognostic stratification?Incidence and prognostic significance of non-enhancing cortical signal abnormality in glioblastoma.Glioblastoma patients in Slovenia from 1997 to 2008.Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas.Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experienceImpact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy.Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme.Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma.Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
P2860
Q24632791-16B83D7F-6AAA-46B7-B027-B17D36A26FFDQ26745588-22D03C75-4572-4AA1-883D-08651A3DFBFDQ26746622-6C00E11B-4C9E-4C5F-8F3D-3080005CF820Q27010046-3CA6470B-643E-4056-B8BA-64928BEFB9F5Q28082603-938F304B-4777-4375-87CE-08B0A5F6D8BFQ30405581-F574D6FD-808A-435A-8AA1-54CAE780B3B6Q30407539-49DB6265-ACD1-4B62-97C3-FE2AADB708B4Q30679537-9E78272F-46B9-4539-B530-5CDB0E3E0BBFQ30819602-053B4193-2FD9-4FAA-8FEF-F8E17A34556EQ30838129-F7A37EFA-CE14-465D-BD06-47E6D996B26EQ31060786-DDEE5910-8EE8-42D3-9DFC-EF6AF219BC26Q33749708-05AA9D92-EFA7-4663-9D5A-7FE896895646Q34438507-38A292C0-BDE6-4FE5-ABDF-3D576691A3F0Q35797779-49BBBDCF-EC3B-41BF-9444-395191114326Q36096097-F44D5B03-DBFD-4DC1-B570-7D53979AC89EQ36642211-9B0D8F24-4790-4A99-BFDE-A48FE50F2B01Q36715973-B8655495-F7F5-4D77-93D5-707EAACFCEB9Q36814867-75550362-1784-4C08-9597-1BE1A78989FBQ36877702-11F0695D-8048-420A-9C76-829EE7AFB5BAQ37037922-3F7E6B11-4246-42AF-8F0A-2873A7383523Q37108692-A3ADE8C0-4143-4540-BE8E-29118979B93BQ37366417-2A01D907-6FE8-4116-A031-591841EA4584Q37409716-1539DC6D-E999-4DAB-BE1D-87BCA6355039Q37632115-70982BC3-1731-4F59-BEE9-9231821866FEQ37876686-EC1000F8-F718-47FA-8BF5-68F7FAF45240Q38107243-C7A97F05-14DE-40C4-BA17-5F86BD1D8C5CQ38156191-323D6BBE-FC43-4523-8226-D9F91F2D2416Q38269839-DAD1CF09-87F3-4D9E-9B1B-0AE0EE031CB7Q38735917-347E5A5B-49BF-410A-9D50-3E5A13689CC2Q38974708-630A4368-A1B4-4DEC-A57E-3271851F0098Q39275344-CF4889CC-2429-420E-A4D3-F89087BCB544Q39711507-ADBD91E8-F4C7-435F-8167-BB6E587C061CQ41103978-42C402A7-AF3C-4FBC-8A6A-06D96E08A003Q41903842-4A5C1B26-47A3-4328-AA04-4D1ABA2D10E0Q42173052-E7EFC123-245B-4B7F-A722-2696F0AB7564Q42289827-BD88763A-7790-4CC3-B34F-55B290960FB7Q42323296-C0867448-2A20-478F-A600-D2B649AF5DB6Q44500841-44AB9270-B0A7-4D8C-A807-2B59CBC63BBBQ45075484-896D1275-2657-4BC9-93D7-C9D8A083C7E1Q47155335-1A20C04E-A332-4E9B-B834-8D909384D584
P2860
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
@en
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
@nl
type
label
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
@en
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
@nl
prefLabel
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
@en
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
@nl
P2093
P1476
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
@en
P2093
Ian R Crocker
Mark W McDonald
Walter J Curran
P304
P356
10.1016/J.IJROBP.2009.10.048
P407
P577
2010-04-14T00:00:00Z